Validation of the MTXPK Tool in Predicting Glucarpidase Utilization Among Patients With Delayed Methotrexate Clearance: A Retrospective Study. [PDF]
CureusWu K, Dadeboyina C, Hua G.
europepmc +1 more source
Cas clínic: ús de la glucarpidasa en la intoxicació per altes dosis de metotrexat en una nena amb leucèmia limfoblàstica aguda [PDF]
Glucarpidasa; Metotrexat; Antídots; Leucèmia infantilGlucarpidasa; Metotrechado; Antídotos; Leucemia infantilGlucarpidase; Methotrexate; Antidotes; Childhood leukemiaEn l’administració d’HDTMX, el més important és evitar el desenvolupament de toxicitats ...
Comes Escoda, Ariadna +1 more
core
Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma. [PDF]
CureusFujiwara Y +3 more
europepmc +1 more source
Boletín de antídotos de Cataluña [PDF]
Antídots; Intoxicació aguda; CatalunyaAntidote; Acute intoxication; CataloniaAntídotos; Intoxicación aguda; CataluñaCas clínic: ús de la glucarpidasa en la intoxicació per altes dosis de metotrexat en una nena amb leucèmia limfoblàstica agudaCaso clínico:
core
A Rare Case of High-Dose Methotrexate Toxicity Precipitated by Piperacillin-Tazobactam: Delayed Clearance, Acute Kidney Injury, and Rescue with Glucarpidase. [PDF]
CureusAbdullah H, Waraich H, Atta K, Atta F.
europepmc +1 more source
Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase. [PDF]
BMJ Case RepPurzycki T, Knapp M, Patel S.
europepmc +1 more source
Beyond the budget impact model: A case study for glucarpidase and the real cost of managing curable toxicities. [PDF]
J Oncol Pharm PractWilliams SA, Weiss RJ.
europepmc +1 more source
Methotrexate toxicity and glucarpidase: A call for dose optimization
British Journal of Clinical PharmacologyArjen Koppen +6 more
openaire +2 more sources
Prevention and Treatment of Acute Kidney Injury Associated with High-Dose Methotrexate. [PDF]
Kidney360Faguer S +3 more
europepmc +1 more source